ID

12862

Description

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056); ODM derived from: https://clinicaltrials.gov/show/NCT00473889

Link

https://clinicaltrials.gov/show/NCT00473889

Keywords

Versions (1)
  1. 1/3/16 1/3/16 -
Uploaded on

January 3, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

English

Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females at least 18 years of age who have confirmed diagnosis of non-small cell lung cancer
Description

age; non-small cell lung cancer

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007131
patients with no systemic prior systemic treatment for lung cancer except patients at least 12 months from prior adjuvant therapy
Description

therapy systemic lung cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0242379
adequate bone marrow,kidney and liver function
Description

organ function adequate; liver function

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205411
UMLS CUI [2]
C0232741
must be recovered and at least 4 weeks from major surgery or radiation
Description

major surgery; radiation

Data type

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0851346
ecog (eastern cooperative oncology group) performance status of 0 or 1
Description

ecog

Data type

boolean

Alias
UMLS CUI [1]
C1520224
men and women must agree to use birth control during the study
Description

contraception status

Data type

boolean

Alias
UMLS CUI [1]
C0420837
women able to have children must have a negative pregnancy test 14 days before study enrollment
Description

negative pregnancy test

Data type

boolean

Alias
UMLS CUI [1]
C0427780
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with prior treatment with other investigational agents less than 4 weeks before study enrollment
Description

investigational agents

Data type

boolean

Alias
UMLS CUI [1]
C1875319
pregnant or nursing female patients
Description

pregnancy; lactating

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients who are hiv positive
Description

hiv positive

Data type

boolean

Alias
UMLS CUI [1]
C0019699
patients who have hepatitis a, b, or c
Description

hepatitis

Data type

boolean

Alias
UMLS CUI [1]
C0019158
patients unable to take study medication by mouth
Description

Oral Route of Drug administration

Data type

boolean

Alias
UMLS CUI [1]
C1527415
patients with untreated brain cancer
Description

brain cancer

Data type

boolean

Alias
UMLS CUI [1]
C0153633
patient eligible for treatment with bevacizumab and for whom bevacizumab is available
Description

bevacizumab

Data type

boolean

Alias
UMLS CUI [1]
C0796392
Back to the top of the page

Similar models

Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
age; non-small cell lung cancer
Item
males and females at least 18 years of age who have confirmed diagnosis of non-small cell lung cancer
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
therapy systemic lung cancer
Item
patients with no systemic prior systemic treatment for lung cancer except patients at least 12 months from prior adjuvant therapy
boolean
C0087111 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,3])
organ function adequate; liver function
Item
adequate bone marrow,kidney and liver function
boolean
C0678852 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
major surgery; radiation
Item
must be recovered and at least 4 weeks from major surgery or radiation
boolean
C0679637 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
ecog
Item
ecog (eastern cooperative oncology group) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
contraception status
Item
men and women must agree to use birth control during the study
boolean
C0420837 (UMLS CUI [1])
negative pregnancy test
Item
women able to have children must have a negative pregnancy test 14 days before study enrollment
boolean
C0427780 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
investigational agents
Item
patients with prior treatment with other investigational agents less than 4 weeks before study enrollment
boolean
C1875319 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or nursing female patients
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
hiv positive
Item
patients who are hiv positive
boolean
C0019699 (UMLS CUI [1])
hepatitis
Item
patients who have hepatitis a, b, or c
boolean
C0019158 (UMLS CUI [1])
Oral Route of Drug administration
Item
patients unable to take study medication by mouth
boolean
C1527415 (UMLS CUI [1])
brain cancer
Item
patients with untreated brain cancer
boolean
C0153633 (UMLS CUI [1])
bevacizumab
Item
patient eligible for treatment with bevacizumab and for whom bevacizumab is available
boolean
C0796392 (UMLS CUI [1])
Back to the top of the page 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial